Physician profile
Daniel Katz
NPI 1013919737
$4,673.84
in general payments reported to CMS, 2019-2025
14 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $1,250 · 2021: $33.97 · 2022: $70.43 · 2023: $122 · 2024: $2,028 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,488 · Consulting Fee: $1,000 · Travel and Lodging: $49.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.30 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $49.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,665.91 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Cook Incorporated | $1,049.58 | 2024 | Gunther Tulip |
| Argon Medical Devices, INC. | $254.98 | 2019 | |
| Shockwave Medical, INC | $176.55 | 2025 | |
| Cook Medical LLC | $124.39 | 2019 | |
| Surmodics, INC. | $117.15 | 2024 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Siemens Medical Solutions USA, INC. | $84.31 | 2019 | |
| Lemaitre Vascular, INC. | $41.61 | 2022-2024 | Hydro Lemaitre Valvulotome |
| Boston Scientific Corporation | $36.76 | 2023 | |
| Janssen Pharmaceuticals, INC | $32.32 | 2020-2021 | |
| Stryker Corporation | $24.80 | 2025 | Artix Mt |
| Dilon Technologies, INC. | $23.62 | 2023 | Hemoblast Bellows |
| Arjo INC. | $22.60 | 2025 | |
| Medtronic, INC. | $19.26 | 2023 | Endurant Iis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.